• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

预测肺鳞状细胞癌患者预后的铁死亡相关长链非编码RNA的系统分析

Systematic analysis of ferroptosis-related long non-coding RNA predicting prognosis in patients with lung squamous cell carcinoma.

作者信息

Yao Ninghua, Zuo Ling, Yan Xiaodi, Qian Jing, Sun Jie, Xu Huawei, Zheng Feifei, Efird Jimmy T, Kawagoe Izumi, Wang Yan, Ni Sujie

机构信息

Department of Cancer Center, Affiliated Hospital of Nantong University, Nantong, China.

Department of Oncology, Nantong University, Nantong, China.

出版信息

Transl Lung Cancer Res. 2022 Apr;11(4):632-646. doi: 10.21037/tlcr-22-224.

DOI:10.21037/tlcr-22-224
PMID:35529787
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9073741/
Abstract

BACKGROUND

Ferroptosis is a novel iron-dependent cell death, and an increasing number of studies have shown that long non-coding RNA (lncRNAs) are involved in the ferroptosis process. However, studies on ferroptosis-related lncRNAs in lung squamous cell carcinoma (LUSC) are limited. In addition, the prognostic role of ferroptosis-related lncRNAs and their relationship with the immune microenvironment and methylation of LUSC is unclear. This study aimed to investigate the potential prognostic value of ferroptosis-related lncRNAs and their involved biological functions in LUSC.

METHODS

The Cancer Genome Atlas (TCGA) database and the FerrDb website were used to obtain ferroptosis-related genes for LUSC. The "limma" R package and Pearson analysis were used to find ferroptosis-related lncRNAs. The biological functions of the characterized lncRNAs were analyzed by Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG). We evaluated the prognostic power of this model using Kaplan-Meier analysis, receiver operating characteristic (ROC), and decision curve analysis (DCA). Univariate and multifactor Cox (proportional-hazards) risk model and a nomogram were produced using risk models and clinicopathological parameters for further verification. In addition, the relationship between characterized lncRNAs and tumor immune infiltration and methylation was also discussed.

RESULTS

We identified 29 characterized lncRNAs to produce prognostic risk models. Kaplan-Meier analysis revealed the high-risk group was associated with poor prognosis in LUSC (P<0.001), and ROC (AUC =0.658) and DCA suggested that risk models could predict prognosis. Univariate and multifactorial Cox as well as nomogram further validated the prognostic model (P<0.001). Gene set enrichment analysis (GSEA) showed that the high-risk group was associated with pro-tumor pathways and high-frequency mutations in TP53 were present in both groups. Single sample gene set enrichment analysis (ssGSEA) showed significant differences in immune cell infiltration subtypes and corresponding functions between the two groups. Some immune checkpoint and methylation-related genes were significantly different between the two groups (P<0.05).

CONCLUSIONS

We investigated the potential mechanisms of LUSC development from the perspective of ferroptosis-related lncRNAs, providing new insights into LUSC research, and identified 29 lncRNAs as biomarkers to predict the prognosis of LUSC patients.

摘要

背景

铁死亡是一种新型的铁依赖性细胞死亡,越来越多的研究表明长链非编码RNA(lncRNAs)参与了铁死亡过程。然而,关于肺鳞状细胞癌(LUSC)中铁死亡相关lncRNAs的研究有限。此外,铁死亡相关lncRNAs的预后作用及其与LUSC免疫微环境和甲基化的关系尚不清楚。本研究旨在探讨铁死亡相关lncRNAs在LUSC中的潜在预后价值及其涉及的生物学功能。

方法

利用癌症基因组图谱(TCGA)数据库和FerrDb网站获取LUSC的铁死亡相关基因。使用“limma”R包和Pearson分析来寻找铁死亡相关lncRNAs。通过基因本体论(GO)和京都基因与基因组百科全书(KEGG)分析所鉴定lncRNAs的生物学功能。我们使用Kaplan-Meier分析、受试者工作特征(ROC)和决策曲线分析(DCA)评估该模型的预后能力。使用风险模型和临床病理参数构建单因素和多因素Cox(比例风险)风险模型和列线图进行进一步验证。此外,还讨论了所鉴定lncRNAs与肿瘤免疫浸润和甲基化之间的关系。

结果

我们鉴定出29个特征性lncRNAs以构建预后风险模型。Kaplan-Meier分析显示,高危组与LUSC的预后不良相关(P<0.001),ROC(AUC =0.658)和DCA表明风险模型可以预测预后。单因素和多因素Cox分析以及列线图进一步验证了预后模型(P<0.001)。基因集富集分析(GSEA)表明,高危组与促肿瘤通路相关,两组均存在TP53高频突变。单样本基因集富集分析(ssGSEA)显示两组之间免疫细胞浸润亚型和相应功能存在显著差异。两组之间一些免疫检查点和甲基化相关基因存在显著差异(P<0.05)。

结论

我们从铁死亡相关lncRNAs的角度研究了LUSC发生发展的潜在机制,为LUSC研究提供了新的见解,并鉴定出29个lncRNAs作为预测LUSC患者预后的生物标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5fc/9073741/e0b919a9aa03/tlcr-11-04-632-f10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5fc/9073741/5caa3e7717ad/tlcr-11-04-632-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5fc/9073741/5566df3aba56/tlcr-11-04-632-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5fc/9073741/1bd1797cff2c/tlcr-11-04-632-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5fc/9073741/4afdb61398c8/tlcr-11-04-632-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5fc/9073741/3af362a4c591/tlcr-11-04-632-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5fc/9073741/c08c1d1d8093/tlcr-11-04-632-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5fc/9073741/0319b7ae7ab2/tlcr-11-04-632-f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5fc/9073741/be49a76dc946/tlcr-11-04-632-f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5fc/9073741/c41695da9822/tlcr-11-04-632-f9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5fc/9073741/e0b919a9aa03/tlcr-11-04-632-f10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5fc/9073741/5caa3e7717ad/tlcr-11-04-632-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5fc/9073741/5566df3aba56/tlcr-11-04-632-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5fc/9073741/1bd1797cff2c/tlcr-11-04-632-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5fc/9073741/4afdb61398c8/tlcr-11-04-632-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5fc/9073741/3af362a4c591/tlcr-11-04-632-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5fc/9073741/c08c1d1d8093/tlcr-11-04-632-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5fc/9073741/0319b7ae7ab2/tlcr-11-04-632-f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5fc/9073741/be49a76dc946/tlcr-11-04-632-f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5fc/9073741/c41695da9822/tlcr-11-04-632-f9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5fc/9073741/e0b919a9aa03/tlcr-11-04-632-f10.jpg

相似文献

1
Systematic analysis of ferroptosis-related long non-coding RNA predicting prognosis in patients with lung squamous cell carcinoma.预测肺鳞状细胞癌患者预后的铁死亡相关长链非编码RNA的系统分析
Transl Lung Cancer Res. 2022 Apr;11(4):632-646. doi: 10.21037/tlcr-22-224.
2
A Novel Prognosis Signature Based on Ferroptosis-Related Gene DNA Methylation Data for Lung Squamous Cell Carcinoma.基于铁死亡相关基因DNA甲基化数据的肺鳞状细胞癌新型预后标志物
J Oncol. 2022 Sep 12;2022:9103259. doi: 10.1155/2022/9103259. eCollection 2022.
3
Identification of a N6-Methyladenosine (m6A)-Related lncRNA Signature for Predicting the Prognosis and Immune Landscape of Lung Squamous Cell Carcinoma.用于预测肺鳞状细胞癌预后和免疫格局的N6-甲基腺苷(m6A)相关长链非编码RNA特征的鉴定
Front Oncol. 2021 Nov 18;11:763027. doi: 10.3389/fonc.2021.763027. eCollection 2021.
4
Identification of Clinical Prognostic Regulators and Analysis of Ferroptosis-Related Signatures in the Tumor Immune Microenvironment in Lung Squamous Cell Carcinoma.肺鳞状细胞癌中肿瘤免疫微环境的临床预后调控因子鉴定及铁死亡相关特征分析。
Dis Markers. 2023 Feb 15;2023:9155944. doi: 10.1155/2023/9155944. eCollection 2023.
5
M7G-Related lncRNAs predict prognosis and regulate the immune microenvironment in lung squamous cell carcinoma.M7G 相关长非编码 RNA 预测肺鳞癌的预后并调节免疫微环境。
BMC Cancer. 2022 Nov 4;22(1):1132. doi: 10.1186/s12885-022-10232-z.
6
Identification and validation of an individualized prognostic signature of lung squamous cell carcinoma based on ferroptosis-related genes.基于铁死亡相关基因的肺鳞状细胞癌个体化预后标志物的鉴定和验证。
Thorac Cancer. 2021 Dec;12(23):3236-3247. doi: 10.1111/1759-7714.14195. Epub 2021 Oct 20.
7
Identification of seven novel ferroptosis-related long non-coding RNA signatures as a diagnostic biomarker for acute myeloid leukemia.鉴定七个新型铁死亡相关长非编码 RNA 特征作为急性髓系白血病的诊断生物标志物。
BMC Med Genomics. 2021 Sep 27;14(1):236. doi: 10.1186/s12920-021-01085-9.
8
The development and validation of a m6A-lncRNAs based prognostic model for overall survival in lung squamous cell carcinoma.基于m6A长链非编码RNA的肺鳞状细胞癌总生存预后模型的构建与验证
J Thorac Dis. 2022 Oct;14(10):4055-4072. doi: 10.21037/jtd-22-1185.
9
Significance of as a biomarker for clinical prognosis, immune infiltration, and drug therapy in lung squamous cell carcinoma.在肺鳞状细胞癌中,作为临床预后、免疫浸润和药物治疗的生物标志物的意义。
PeerJ. 2024 May 1;12:e17338. doi: 10.7717/peerj.17338. eCollection 2024.
10
Identification of lncRNA biomarkers in lung squamous cell carcinoma using comprehensive analysis of lncRNA mediated ceRNA network.采用长链非编码 RNA 介导 ceRNA 网络的综合分析鉴定肺鳞状细胞癌中的 lncRNA 生物标志物。
Artif Cells Nanomed Biotechnol. 2019 Dec;47(1):3246-3258. doi: 10.1080/21691401.2019.1647225.

引用本文的文献

1
Associations between immune cell phenotypes and lung cancer subtypes: insights from mendelian randomization analysis.免疫细胞表型与肺癌亚型的相关性:孟德尔随机化分析的启示。
BMC Pulm Med. 2024 May 16;24(1):242. doi: 10.1186/s12890-024-03059-w.
2
Establishment of a prognosis prediction model for lung squamous cell carcinoma related to PET/CT: basing on immunogenic cell death-related lncRNA.基于免疫原性细胞死亡相关长非编码 RNA 的肺鳞状细胞癌 PET/CT 预后预测模型的建立。
BMC Pulm Med. 2023 Dec 15;23(1):511. doi: 10.1186/s12890-023-02792-y.
3
Construction and validation of a cuproptosis-related lncRNA signature for the prediction of the prognosis of LUAD and LUSC.

本文引用的文献

1
Ferroptosis-Related IncRNAs Are Prognostic Biomarker of Overall Survival in Pancreatic Cancer Patients.铁死亡相关长链非编码RNA是胰腺癌患者总生存期的预后生物标志物。
Front Cell Dev Biol. 2022 Feb 10;10:819724. doi: 10.3389/fcell.2022.819724. eCollection 2022.
2
Identification and Validation of Ferroptosis-Related LncRNA Signatures as a Novel Prognostic Model for Colon Cancer.鉴定和验证与铁死亡相关的 lncRNA 特征作为结肠癌的一种新的预后模型。
Front Immunol. 2022 Jan 26;12:783362. doi: 10.3389/fimmu.2021.783362. eCollection 2021.
3
Construction of a Ferroptosis-Related Long Non-coding RNA Prognostic Signature and Competing Endogenous RNA Network in Lung Adenocarcinoma.
构建并验证一个与铜死亡相关的 lncRNA 标志物,用于预测 LUAD 和 LUSC 的预后。
Sci Rep. 2023 Feb 11;13(1):2477. doi: 10.1038/s41598-023-29719-1.
4
LINC00669 promotes lung adenocarcinoma growth by stimulating the Wnt/β-catenin signaling pathway.LINC00669 通过激活 Wnt/β-catenin 信号通路促进肺腺癌生长。
Cancer Med. 2023 Apr;12(7):9005-9023. doi: 10.1002/cam4.5604. Epub 2023 Jan 9.
5
Ferroptosis-related lncRNAs signature to predict the survival and immune evasion for lung squamous cell carcinoma.用于预测肺鳞状细胞癌生存和免疫逃逸的铁死亡相关长链非编码RNA特征
Front Genet. 2022 Aug 26;13:968601. doi: 10.3389/fgene.2022.968601. eCollection 2022.
6
Identification of Ferroptosis-Associated Long Noncoding RNA Prognostic Model and Tumor Immune Microenvironment in Thyroid Cancer.识别甲状腺癌中与铁死亡相关的长链非编码 RNA 预后模型和肿瘤免疫微环境。
J Immunol Res. 2022 Jul 20;2022:5893998. doi: 10.1155/2022/5893998. eCollection 2022.
7
Identification of metabolism-related long non-coding RNA (lncRNA) signature predicts prognosis and immune infiltrates in hepatocellular carcinoma.代谢相关长链非编码RNA(lncRNA)特征的鉴定可预测肝细胞癌的预后和免疫浸润。
Ann Transl Med. 2022 May;10(10):595. doi: 10.21037/atm-22-2194.
肺腺癌中铁死亡相关长链非编码RNA预后特征及竞争性内源性RNA网络的构建
Front Cell Dev Biol. 2021 Nov 8;9:751490. doi: 10.3389/fcell.2021.751490. eCollection 2021.
4
N-methyladenosine modification regulates ferroptosis through autophagy signaling pathway in hepatic stellate cells.N6-甲基腺苷修饰通过自噬信号通路调控肝星状细胞中的铁死亡。
Redox Biol. 2021 Nov;47:102151. doi: 10.1016/j.redox.2021.102151. Epub 2021 Sep 26.
5
Construction of a Ferroptosis-Related Nine-lncRNA Signature for Predicting Prognosis and Immune Response in Hepatocellular Carcinoma.构建铁死亡相关的九个长链非编码 RNA 标志物用于预测肝细胞癌的预后和免疫反应。
Front Immunol. 2021 Sep 17;12:719175. doi: 10.3389/fimmu.2021.719175. eCollection 2021.
6
Heme Oxgenase-1, a Cardinal Modulator of Regulated Cell Death and Inflammation.血红素加氧酶-1,调节细胞死亡和炎症的关键调节因子。
Cells. 2021 Feb 28;10(3):515. doi: 10.3390/cells10030515.
7
The Effect of Advances in Lung-Cancer Treatment on Population Mortality.肺癌治疗进展对人群死亡率的影响。
N Engl J Med. 2020 Aug 13;383(7):640-649. doi: 10.1056/NEJMoa1916623.
8
Immune microenvironment composition in non-small cell lung cancer and its association with survival.非小细胞肺癌中的免疫微环境组成及其与生存的关联。
Clin Transl Immunology. 2020 Jun 12;9(6):e1142. doi: 10.1002/cti2.1142. eCollection 2020.
9
MIR22HG regulates miR-486/PTEN axis in bladder cancer to promote cell proliferation.MIR22HG 通过调控 miR-486/PTEN 轴促进膀胱癌细胞增殖。
Biosci Rep. 2020 Jun 26;40(6). doi: 10.1042/BSR20193991.
10
TGF-β1-mediated repression of SLC7A11 drives vulnerability to GPX4 inhibition in hepatocellular carcinoma cells.TGF-β1 通过抑制 SLC7A11 表达增加肝癌细胞对 GPX4 抑制剂的敏感性。
Cell Death Dis. 2020 May 29;11(5):406. doi: 10.1038/s41419-020-2618-6.